Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.00% | 205.10 | 1.2% | $477.70m | |
| GILD | Gilead Sciences, Inc. | 0.91% | 75.51 | 0.9% | $401.46m | |
| BIIB | Biogen Inc. | 1.22% | 345.41 | 1.3% | $352.23m | |
| CELG | Celgene Corporation | -0.66% | 87.72 | 1.2% | $341.18m | |
| ILMN | Illumina, Inc. | 0.52% | 358.16 | 3.5% | $248.76m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.78% | 390.28 | 2.6% | $232.51m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.24% | 180.08 | 1.9% | $168.98m | |
| EXAS | Exact Sciences Corporation | 1.72% | 76.28 | 25.3% | $162.68m | |
| SRPT | Sarepta Therapeutics, Inc. | -3.43% | 147.59 | 16.4% | $129.44m | |
| A | Agilent Technologies, Inc. | -0.58% | 70.72 | 1.5% | $124.93m | |
| VKTX | Viking Therapeutics, Inc. | -4.06% | 18.20 | 0.9% | $115.92m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.10% | 121.99 | 2.0% | $114.40m | |
| NKTR | Nektar Therapeutics | 0.96% | 59.00 | 5.6% | $106.74m | |
| BMRN | BioMarin Pharmaceutical Inc. | -2.55% | 97.84 | 4.4% | $97.41m | |
| ALNY | Alnylam Pharmaceuticals, Inc | -0.67% | 94.57 | 9.7% | $93.14m |
Company Profile
Oragenics, Inc. is a biopharmaceutical company, which focuses on the development of novel antibiotics and treatments against infectious disease and oral mucositis. Its technology and pipeline is comprised of lantibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Tampa, FL.